Carlsmed names Richard Heppenstall CFO, reaffirms 2026 revenue guidance

Carlsmed named Richard Heppenstall chief financial officer, effective immediately, replacing Leo Greenstein. Heppenstall was previously CFO at ZimVie and Breg. Full-year 2026 revenue guidance was reaffirmed at $74 million to $78 million.